Published in J R Soc Med on June 01, 1981
Endogenous opioids and pain: a review. J R Soc Med (1982) 0.75
Opiate receptor: demonstration in nervous tissue. Science (1973) 6.06
Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res (1975) 3.26
C fragment of lipotropin has a high affinity for brain opiate receptors. Nature (1976) 2.62
Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science (1976) 2.35
Naloxone blockade of acupuncture analgesia: endorphin implicated. Life Sci (1976) 1.82
Central nervous system mechanisms of analgesia. Pain (1976) 1.69
Opioid antagonists. Pharmacol Rev (1967) 1.67
The narcotic antagonist naloxone enhances clinical pain. Nature (1978) 1.66
Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors. Br J Pharmacol (1980) 1.47
Opiate and stimulus-produced analgesia: functional anatomy of a medullospinal pathway. Proc Natl Acad Sci U S A (1976) 1.43
Nitrous oxide analgesia: reversal by naloxone and development of tolerance. J Pharmacol Exp Ther (1977) 1.35
On the specificity of naloxone as an opiate antagonist. Life Sci (1979) 1.33
Suppression of transmission of nociceptive impulses by morphine: selective effects of morphine administered in the region of the substantia gelatinosa. Br J Pharmacol (1977) 1.22
Endorphin-mediated inhibition of locus coeruleus neurons. Brain Res (1980) 1.09
A pituitary endorphin with novel properties. Life Sci (1979) 1.09
Naloxone reversal of analgesia produced by brain stimulation in the human. Pain (1976) 1.03
Acupuncture reduces electrophysiological and behavioral responses to noxious stimuli: pituitary is implicated. Exp Neurol (1977) 1.02
Biology of opioid peptides. Annu Rev Pharmacol Toxicol (1979) 1.01
Comparison of the receptor binding characteristics of opiate agonists interacting with mu- or kappa-receptors. Br J Pharmacol (1978) 0.98
The effect of the narcotic antagonists naloxone, naltrexone and nalorphine on spinal cord C-fiber reflexes evoked by electrical stimulation or radiant heat. Eur J Pharmacol (1977) 0.96
Endogenous opioid ligands may mediate stress-induced changes in the affective properties of pain related behavior in rats. Life Sci (1978) 0.95
Effects of tyrosyl-arginine (kyotorphin), a new opioid dipeptide, on single neurons in the spinal dorsal horn of rabbits and the nucleus reticularis paragigantocellularis of rats. Neurosci Lett (1980) 0.86
Opioid antagonists, endogenous ligands and nociception. Eur J Pharmacol (1977) 0.86
Morphine-induced and stimulation-produced analgesias at coincident periaqueductal central gray loci: evaluation of analgesic congruence, tolerance, and cross-tolerance. Exp Neurol (1977) 0.85
The influence of naloxone on the C fiber response of dorsal horn neurons and their inhibitory control by raphe magnus stimulation. Brain Res (1979) 0.84
Regulation of prolactin release by endogenous opiates. Nature (1977) 0.83
Analgesia following transcutaneous electrical stimulation and its partial reversal by a narcotic antagonist. Life Sci (1977) 0.83
Footshock induced analgesia in mice: its reversal by naloxone and cross tolerance with morphine. Life Sci (1977) 0.82
Selective depression by opioid peptides of sensory-evoked dorsal-horn network responses in organized spinal cord cultures. Brain Res (1978) 0.80
Congenital insensitivity to pain and the "morphine-like" analgesic system. Pain (1978) 0.80
Enkephalinase: selective inhibitors and partial characterization. Peptides (1980) 0.80
The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate. Brain Res (1979) 0.79
Effect of Lissauer tract stimulation on activity in dorsal roots and in ventral roots. Exp Neurol (1978) 0.79
Repeated failure of nickel-containing prosthetic heart valves in a patient allergic to nickel. Lancet (1978) 0.78
Use of naloxone in opiate poisoning. Br Med J (1973) 0.78
Alcohol-induced pituitary adenolysis: how does it control intractable cancer pain?--An experimental study using tooth pulp-evoked potentials in rhesus monkeys. Anesth Analg (1979) 0.78
Endorphins and clinical pain, an overview. Adv Exp Med Biol (1979) 0.78
[Abolition by naloxone of the inhibitory effect of peripheral electrical stimulation on the blink reflex]. Electroencephalogr Clin Neurophysiol (1979) 0.78
Diazepam-induced release of opioid activity in the rat brain. Neurosci Lett (1980) 0.77
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 2.83
Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia (1997) 1.99
A method for comparing the potencies of -aminobutyric acid antagonists on single cortical neurones using micro-iontophoretic techniques. Br J Pharmacol (1973) 1.82
Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology (1999) 1.60
Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology (1999) 1.48
A comparative study of some convulsant substances as gamma-aminobutyric acid antagonists in the feline cerebral cortex. Br J Pharmacol (1973) 1.45
Targeted disruption of a B2 bradykinin receptor gene in mice eliminates bradykinin action in smooth muscle and neurons. J Biol Chem (1995) 1.40
A technique allowing e.e.g. and activity recording together with intraventricular administration of drugs in the conscious rabbit. Br J Pharmacol (1973) 1.39
Bicyclic phosphorus esters that are potent convulsants and GABA antagonists. Nature (1976) 1.37
Antagonism of GABA by picrotoxin in the feline cerebral cortex. Br J Pharmacol (1972) 1.37
Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther (1995) 1.37
Evaluation of bicuculline as a GABA antagonist. Nature (1971) 1.35
Evidence that bicuculline can both potentiate and antagonize GABA. Br J Pharmacol (1971) 1.34
Convulsive properties of d-tubocurarine and cortical inhibition. Nature (1972) 1.25
Rat hippocampal slices 'in vitro' display spontaneous epileptiform activity following long-term organotypic culture. J Neurosci Methods (1989) 1.24
kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat. Br J Pharmacol (1988) 1.23
Effects of cholecystokinin and related peptides on neuronal activity in the ventromedial nucleus of the rat hypothalamus. Br J Pharmacol (1988) 1.19
Effects of a focal penicillin lesion on responses of rabbit cortical neurones to putative neurotransmitters. Br J Pharmacol (1972) 1.19
Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs. Can J Physiol Pharmacol (1997) 1.16
Neurotransmitter candidates of somatosensory primary afferent fibres. Neuroscience (1983) 1.15
Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia (1997) 1.15
Fracture toughness of acrylic denture base. Biomaterials (1983) 1.13
Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology (1996) 1.12
Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies. Cephalalgia (1997) 1.12
The non-peptide neurokinin1 receptor antagonist, RP 67580, blocks neurogenic plasma extravasation in the dura mater of rats. Br J Pharmacol (1993) 1.10
Expression of B1 and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice. Neuropharmacology (1997) 1.08
Crystallization modifies osteoconductivity in an apatite-mullite glass-ceramic. J Mater Sci Mater Med (2003) 1.08
Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology (1995) 1.05
The novel NK1 receptor antagonist MK-0869 (L-754,030) and its water soluble phosphoryl prodrug, L-758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets. Neuropharmacology (2000) 1.04
Proceedings: Presynaptic inhibition and the depressant actions of GABA and glycine in the feline cuneate nucleus: changes related to electrographic seizure activity. J Physiol (1973) 1.02
Amino acid antagonists and the depression of cuneate neurones by -aminobutyric acid (GABA) and glycine. Br J Pharmacol (1973) 1.01
Plus and minus-bicuculline methochloride as optical isomers of a GABA antagonist. Nature (1974) 1.01
The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation. Eur J Pharmacol (1997) 1.01
Microiontophoretic release of drugs from micropipettes: use of 24Na as a model. Br J Pharmacol (1973) 1.01
Actions of the GABAB agonist, (-)-baclofen, on neurones in deep dorsal horn of the rat spinal cord in vitro. Br J Pharmacol (1989) 1.00
Excitation of single sensory neurones in the rat caudal trigeminal nucleus by iontophoretically applied adenosine 5'-triphosphate. Neurosci Lett (1983) 1.00
Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur J Neurosci (2001) 1.00
Antagonism of gamma-aminobutyric acid and glycine by convulsants in the cuneate nucleus of cat. Br J Pharmacol (1976) 1.00
A preliminary comparison of the mechanical properties of chemically cured and ultrasonically cured glass ionomer cements, using nano-indentation techniques. Biomaterials (2001) 1.00
Influence of sodium oxide content on bioactive glass properties. J Mater Sci Mater Med (1999) 1.00
Effects of the bradykinin B1 receptor antagonist des-Arg9[Leu8]bradykinin and genetic disruption of the B2 receptor on nociception in rats and mice. Pain (1997) 0.99
Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994. Neuropharmacology (1994) 0.99
Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation. Br J Clin Pharmacol (1999) 0.99
Antagonism by folic acid of presynaptic inhibition in the rat cuneate nucleus. Br J Pharmacol (1974) 0.99
The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin. Br J Pharmacol (1988) 0.98
Pharmacological profile of PD 117302, a selective kappa-opioid agonist. Br J Pharmacol (1987) 0.98
In vivo evidence for spinal delta-opiate receptor operated antinociception. Neuropeptides (1986) 0.97
Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses. Cephalalgia (1998) 0.97
L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assays. Eur J Pharmacol (1996) 0.96
PD117302: a selective agonist for the kappa-opioid receptor. Br J Pharmacol (1988) 0.96
Rizatriptan has central antinociceptive effects against durally evoked responses. Eur J Pharmacol (1997) 0.96
Effects of the delta-opioid receptor antagonist naltrindole on antinociceptive responses to selective delta-agonists in post-weanling rats. Br J Pharmacol (1992) 0.96
The effect of phosphate content on the bioactivity of soda-lime-phosphosilicate glasses. J Mater Sci Mater Med (2009) 0.95
Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist. Br J Pharmacol (1999) 0.94
Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats. Br J Pharmacol (2001) 0.94
Proceedings: Some neuropharmacological properties of the new non-barbiturate hypnotic etomidate (R (+)-ethyl-1-(alpha-methyl-benzyl) imidazole-5-carboxylate). Br J Pharmacol (1975) 0.94
Effect of RP 67580, a non-peptide neurokinin1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat. Br J Pharmacol (1993) 0.94
Antinociceptive activity of NK1 receptor antagonists: non-specific effects of racemic RP67580. Br J Pharmacol (1993) 0.93
Kappa opioid receptor activation depresses excitatory synaptic input to rat locus coeruleus neurons in vitro. Neuroscience (1987) 0.93
Region selective up-regulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice. Neuroscience (2003) 0.93
Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors. Br J Clin Pharmacol (1998) 0.93
An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres. Cephalalgia (2002) 0.92
The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs. Br J Pharmacol (2001) 0.92
Depression of nociceptive and other neurones in the brain by iontophoretically applied met-enkephalin. Nature (1976) 0.91
Effects of cholecystokinin and pentagastrin on rat hippocampal neurones maintained in vitro. Neuropeptides (1988) 0.91
Structural analysis of a series of strontium-substituted apatites. Acta Biomater (2008) 0.91
Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea-pig jugular vein. Eur J Pharmacol (1995) 0.90
Effects of two truncated forms of human calcitonin-gene related peptide: implications for receptor classification. Eur J Pharmacol (1994) 0.90
Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats. Neuropharmacology (1997) 0.90
Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries. Eur J Pharmacol (2001) 0.90
The behavioural effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats. Neuropharmacology (1984) 0.89
Influence of alkali metal ions on the fracture properties of glass polyalkenoate (ionomer) cements. Biomaterials (1998) 0.88
Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo. Neuroscience (1999) 0.88
Microiontophoretic study of depressant amino acids and the specificity of their antagonists. Br J Pharmacol (1973) 0.88
The depolarising action of capsaicin on rat isolated sciatic nerve. Life Sci (1984) 0.88
The kainate/quisqualate receptor antagonist, CNQX, blocks the fast component of spontaneous epileptiform activity in organotypic cultures of rat hippocampus. Neurosci Lett (1988) 0.88
Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils. Pain (1996) 0.87
In vivo response of strontium and zinc-based ionomeric cement implants in bone. J Mater Sci Mater Med (2002) 0.87
Influence of cement layer thickness on the adhesive bond strength of polyalkenoate cements. Biomaterials (1992) 0.87
Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Br J Pharmacol (1993) 0.87
Potentiation of GABA by midazolam and its therapeutic effect against status epilepticus. Folia Psychiatr Neurol Jpn (1983) 0.87
Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices. Eur J Pharmacol (1995) 0.87
Influence of glass composition on the properties of glass polyalkenoate cements. Part I: influence of aluminium to silicon ratio. Biomaterials (1999) 0.87
The effect of casting conditions on the biaxial flexural strength of glass-ceramic materials. Dent Mater (1998) 0.87
Influence of glass composition on the properties of glass polyalkenoate cements. Part IV: influence of fluorine content. Biomaterials (2000) 0.87
Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism. Neurochem Res (1993) 0.87
Highly selective kappa opioid analgesics. Synthesis and structure-activity relationships of novel N-[(2-aminocyclohexyl)aryl]acetamide and N-[(2-aminocyclohexyl)aryloxy]acetamide derivatives. J Med Chem (1988) 0.86
GABA-mimetic action of etomidate. Experientia (1978) 0.86
Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studies. J Pharmacol Exp Ther (1995) 0.86
The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats. Eur J Pharmacol (1998) 0.86
Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors. Neuropharmacology (1987) 0.86
The influence of polyacid molecular weight on some properties of glass-ionomer cements. J Dent Res (1989) 0.85
The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret. Eur J Pharmacol (1993) 0.85
L-745,337: a selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacology (1994) 0.85
Differentiation of excitatory amino acid receptors in the rat caudal trigeminal nucleus: a microiontophoretic study. Neuropharmacology (1982) 0.85
Excitatory amino acids as transmitter candidates of vibrissae afferent fibres to the rat trigeminal nucleus caudalis. Neurosci Lett (1981) 0.85
Comparison of two heat-pressed all-ceramic dental materials. Dent Mater (2000) 0.85
Enantiospecific inhibition of emesis induced by nicotine in the house musk shrew (Suncus murinus) by the neurokinin1 (NK1) receptor antagonist CP-99,994. Neuropharmacology (1995) 0.85
An ionophoretic study of the responses of rat caudal trigeminal nucleus neurones to non-noxious mechanical sensory stimuli. J Physiol (1982) 0.84